# FDA Inspection 1102782 - Integris Bioservices LLC - June 13, 2019

Source: https://www.keypedia.com/records/fda_inspections/integris-bioservices-llc/d011c509-d138-4a39-9e77-00ddd22fdfbe
Source feed: FDA_Inspections

> FDA Inspection 1102782 for Integris Bioservices LLC on June 13, 2019. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1102782
- Company Name: Integris Bioservices LLC
- Inspection Date: 2019-06-13
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1279931 - 2025-08-29](https://www.keypedia.com/records/fda_inspections/integris-bioservices-llc/39e76d1a-949e-4ce8-a85f-df88ae062acd)
- [FDA Inspection 1223662 - 2023-10-20](https://www.keypedia.com/records/fda_inspections/integris-bioservices-llc/85a3a6fd-39d0-413d-995b-2131a27aee79)

Company: https://www.keypedia.com/companies/integris-bioservices-llc/1f2e0885-338c-49d4-9afd-14924079d628

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c